These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 19380521)

  • 21. Proteomic differential display analysis identified upregulated astrocytic phosphoprotein PEA-15 in human malignant pleural mesothelioma cell lines.
    Kuramitsu Y; Miyamoto H; Tanaka T; Zhang X; Fujimoto M; Ueda K; Tanaka T; Hamano K; Nakamura K
    Proteomics; 2009 Nov; 9(22):5078-89. PubMed ID: 19771552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.
    Suzuki Y; Sakai K; Ueki J; Xu Q; Nakamura T; Shimada H; Nakamura T; Matsumoto K
    Int J Cancer; 2010 Oct; 127(8):1948-57. PubMed ID: 20104519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rational bases for the development of EGFR inhibitors for cancer treatment.
    Bianco R; Gelardi T; Damiano V; Ciardiello F; Tortora G
    Int J Biochem Cell Biol; 2007; 39(7-8):1416-31. PubMed ID: 17596994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sphingosine 1-phosphate transactivates c-Met as well as epidermal growth factor receptor (EGFR) in human gastric cancer cells.
    Shida D; Kitayama J; Yamaguchi H; Yamashita H; Mori K; Watanabe T; Yatomi Y; Nagawa H
    FEBS Lett; 2004 Nov; 577(3):333-8. PubMed ID: 15556605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rescue screens with secreted proteins reveal compensatory potential of receptor tyrosine kinases in driving cancer growth.
    Harbinski F; Craig VJ; Sanghavi S; Jeffery D; Liu L; Sheppard KA; Wagner S; Stamm C; Buness A; Chatenay-Rivauday C; Yao Y; He F; Lu CX; Guagnano V; Metz T; Finan PM; Hofmann F; Sellers WR; Porter JA; Myer VE; Graus-Porta D; Wilson CJ; Buckler A; Tiedt R
    Cancer Discov; 2012 Oct; 2(10):948-59. PubMed ID: 22874768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mevastatin-induced neurite outgrowth of neuroblastoma cells via activation of EGFR.
    Evangelopoulos ME; Weis J; Krüttgen A
    J Neurosci Res; 2009 Jul; 87(9):2138-44. PubMed ID: 19224573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: prognostic correlations.
    Rena O; Boldorini LR; Gaudino E; Casadio C
    J Surg Oncol; 2011 Nov; 104(6):701-5. PubMed ID: 21437912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The plexin-A1 receptor activates vascular endothelial growth factor-receptor 2 and nuclear factor-kappaB to mediate survival and anchorage-independent growth of malignant mesothelioma cells.
    Catalano A; Lazzarini R; Di Nuzzo S; Orciari S; Procopio A
    Cancer Res; 2009 Feb; 69(4):1485-93. PubMed ID: 19176370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue and serum EGFR as prognostic factors in malignant pleural mesothelioma.
    Gaafar R; Bahnassy A; Abdelsalam I; Kamel MM; Helal A; Abdel-Hamid A; Eldin NA; Mokhtar N
    Lung Cancer; 2010 Oct; 70(1):43-50. PubMed ID: 20347505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
    Kim SH; Song YC; Kim SH; Jo H; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():642-8. PubMed ID: 19723115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteopontin modulates malignant pleural mesothelioma cell functions in vitro.
    Ohashi R; Tajima K; Takahashi F; Cui R; Gu T; Shimizu K; Nishio K; Fukuoka K; Nakano T; Takahashi K
    Anticancer Res; 2009 Jun; 29(6):2205-14. PubMed ID: 19528482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of three novel human malignant pleural mesothelioma cell lines: morphological and cytogenetical studies and EGFR mutation status.
    Kobayashi M; Takeuchi T; Ohtsuki Y
    Anticancer Res; 2008; 28(1A):197-208. PubMed ID: 18383846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies.
    Weinberger PM; Yu Z; Kowalski D; Joe J; Manger P; Psyrri A; Sasaki CT
    Arch Otolaryngol Head Neck Surg; 2005 Aug; 131(8):707-11. PubMed ID: 16103303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteopontin is linked to p65 and MMP-9 expression in pulmonary adenocarcinoma but not in malignant pleural mesothelioma.
    Frey AB; Wali A; Pass H; Lonardo F
    Histopathology; 2007 May; 50(6):720-6. PubMed ID: 17493236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma.
    Opitz I; Sigrist B; Hillinger S; Lardinois D; Stahel R; Weder W; Hopkins-Donaldson S
    Lung Cancer; 2007 Jun; 56(3):327-36. PubMed ID: 17383050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma.
    Ou WB; Hubert C; Corson JM; Bueno R; Flynn DL; Sugarbaker DJ; Fletcher JA
    Neoplasia; 2011 Jan; 13(1):12-22. PubMed ID: 21245936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivity of integrin-linked kinase in human mesothelial cell proliferation.
    Watzka SB; Setinek U; Huber M; Cantonati H; Lax F; Watson S; Weigel G; Müller MR
    Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):107-10. PubMed ID: 18048409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EGFR-dependent migration of glial cells is mediated by reorganisation of N-cadherin.
    Rappl A; Piontek G; Schlegel J
    J Cell Sci; 2008 Dec; 121(Pt 24):4089-97. PubMed ID: 19033391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor effect and antiangiogenic potential of the mTOR inhibitor temsirolimus against malignant pleural mesothelioma.
    Moriya M; Yamada T; Tamura M; Ishikawa D; Hoda MA; Matsumoto I; Klepetko W; Oda M; Yano S; Watanabe G
    Oncol Rep; 2014 Mar; 31(3):1109-15. PubMed ID: 24378576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A redox-silent analogue of tocotrienol acts as a potential cytotoxic agent against human mesothelioma cells.
    Kashiwagi K; Virgona N; Harada K; Kido W; Yano Y; Ando A; Hagiwara K; Yano T
    Life Sci; 2009 May; 84(19-20):650-6. PubMed ID: 19232361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.